Stocks making the biggest moves midday: FedEx, Oracle, Johnson & Johnson and more


In this article

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019.
Mark Ralston | AFP | Getty Images

Check out the companies making headlines in midday trading.

Johnson & Johnson — Shares of Johnson & Johnson fell 2.2% after the Centers for Disease Control and Prevention recommended Moderna and Pfizer vaccines for Covid-19 over the Johnson & Johnson vaccine on Thursday. The CDC confirmed 54 cases of people developing blood clots and showing low blood platelet levels after the Johnson & Johnson vaccine. Moderna shares gained nearly 3%. Pfizer lost 2.7%, however, after it said it would amend its study with BioNTech of its Covid-19 vaccine in children between 6 months and under 5 years of age.

Cerner — The health-care information company’s stock jumped more than 12% following new that it’s in talks about a potential sale to Oracle. The deal could be worth $30 billion, according to the Wall Street Journal. Shares of Oracle fell 5.7%.

FedEx — Shares of the shipping company jumped more than 4% after quarterly earnings and revenue results topped expectations and it announced a $5 billion buyback. FedEx also reinstated its original 2022 EPS forecast.

General Motors — GM lost more than 5% following news that Dan Ammann, CEO of its San Francisco area-based self-driving car company Cruise, has left the company. Cruise founder Kyle Vogt will be interim CEO.

Rivian Automotive — Electric vehicle maker Rivian saw shares fell more than 11% after reporting its first quarterly results as a public company and cut its 2021 vehicle production target, expecting to fall “a few hundred vehicles short” of its 1,200 vehicle target.

Darden Restaurants — Shares of the restaurant company slid more than 4% after CEO Gene Lee announced plans to retire on May 29. The Olive Garden parent earned $1.48 per share during the second quarter on $2.27 billion in revenue. Wall Street analysts were expecting the company to earn $1.43 per share on $2.23 billion in revenue, according to Refinitiv.

Winnebago — The camper slipped 0.2% after reporting a sizeable beat on the bottom line for its fiscal first quarter. Winnebago earned $3.51 per share, compared with FactSet’s consensus estimate of $2.34 and revenue that also came in above analysts’ forecasts.

Banks — Financial stocks were among the biggest laggards Friday as bond yields fell amid heightened fears about the omicron variant. Wells Fargo and Goldman Sachs slid 3.9%. Morgan Stanley lost more than 3%, and JPMorgan lost roughly 2.4%.

Eli Lilly — Shares of the pharmaceutical company fell 4% after competitor Biogen’s drug for Alzheimer’s Disease received a negative opinion from European health regulators. Eli Lilly began the application process for approval of its own Alzheimer’s drug in the U.S. in October and is expecting a regulatory decision next year. Goldman Sachs also initiated Eli Lilly stock as neutral with a $236 target, implying 15% downside.

 — CNBC’s Yun Li and Pippa Stevens contributed reporting.

Products You May Like

Articles You May Like

Why Hawaii is becoming a leader in U.S. EV adoption
What to expect from bank earnings as high interest rates pressure smaller players
JPMorgan Chase is set to report first-quarter earnings — here’s what the Street expects
Fewer students are graduating from college, but certificate programs are way up
Goldman Sachs promotes head of strategy and investor relations, Carey Halio, to global treasurer

Leave a Reply

Your email address will not be published. Required fields are marked *